VIJAYA

Vijaya Diagnostic Centre, a small-cap player in the healthcare services sector, The company's financial performance for the first quarter of FY25-26 has been flat, raising concerns about its long-term growth prospects. Over the past five years, net sales have increased at an annual rate of 12.35%, while operating profit has grown at 7.41%. The company's cash and cash equivalents have reached a low of Rs 48.88 crore, and it is noted for having a high valuation with a return on capital employed (ROCE) of 23. The enterprise value to capital employed ratio stands at 12.6, indicating a premium compared to peers. Despite generating a return of 32.88% over the past year, profits have only risen by 20.2%, resulting in a PEG ratio of 3.6. On a positive note, Vijaya Diagnostic Centre boasts high management efficiency with a return on equity (ROE) of 17.31% and a low debt-to-equity ratio of 0.08 times. Institutional holdings are significant at 43.63%, reflecting increased confidence among institutional investors.